Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT

Clin Nucl Med. 2010 Sep;35(9):701-3. doi: 10.1097/RLU.0b013e3181e9faf5.

Abstract

A 57-year-old man with an adenocarcinoma of the prostate, presented with multiple lymph nodes in the para-aortic and right iliac region on computer tomography (CT). However, since the radiologic images were taken 3 weeks following an urosepsis, the differentiation between inflamed and metastatic lymph nodes is difficult. Thus, an integrated [C] choline positron emission tomography and computer tomography (PET/CT) was performed, showing multiple lymph nodes. The patient was staged as cT3N1M0 and treated with hormonal therapy. The choline PET/CT performed after hormonal treatment showed no more hypermetabolic lymph nodes. This case substantiate the hypothesis that choline PET/CT could be used to evaluate therapy response in prostate cancer patients.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Carbon Radioisotopes
  • Choline*
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography*
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / drug therapy*
  • Tomography, X-Ray Computed*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Carbon Radioisotopes
  • Choline